Legal Updates

Santen: A clear view of drug repurposing and a loss of sleep for those relying on Neurim

The CJEU has dealt a massive blow to the drug repurposing sector with its decision in Santen, stripping companies of their right to Supplementary Protection Certificates (SPCs), and overturning one of the most influential SPC cases of all time: Neurim. SPCs provide up to five years of market exclusivity for...

Read more

The Notional Business Person at the EPO II – New Hardware

The EPO Boards of Appeal have been developing a useful body of case law in the business method space in which the concept of a ‘notional business person’ is introduced in order to help with the task of determining just what can and cannot be included in the requirements specification...

Read more

SPCs: What it means to be protected by a patent

Further guidance has come from the CJEU on the disclosure requirements in a patent of a medicinal drug for it to be awarded a Supplementary Protection Certificate (SPC), and the associated market exclusivity, in Europe. Unlike the case for infringement, it is not enough for the medicinal drug, or “product”,...

Read more

Hearings Digest 2019

Our Computer Technology patent attorney team have produced a 2019 UK hearings digest that provides analysis of the decisions issued by the UKIPO relating to computer implemented inventions (CII). Whether you work as in-house counsel or in overseas private practice, you should find the hints and tips for prosecuting CII applications useful,...

Read more

UPC – Germany looking to get back on track

News on the Unified Patent Court (UPC) this month has been like London buses – no news for months and then one update, followed by another, and now a third. The latest news is that Christine Lambrecht, German Federal Minister of Justice and Consumer Protection, has confirmed, following the decision...

Read more